Patent Pools for CRISPR Technology — Response

Science, Vol. 355(6331), pp. 1274-1275 (2017)

Posted: 28 Jun 2017 Last revised: 13 Nov 2019

See all articles by Jorge L. Contreras

Jorge L. Contreras

University of Utah - S.J. Quinney College of Law

Jacob S. Sherkow

University of Illinois College of Law; Carle Illinois College of Medicine; University of Illinois at Urbana-Champaign - European Union Center; University of Illinois at Urbana-Champaign - Carl R. Woese Institute for Genomic Biology

Date Written: March 24, 2017

Abstract

In response to a letter from Lawrence Horn, MPEG LA, suggesting patent pools for CRISPR licensing, we respond that while patent pools have been successfully deployed in the consumer electronics and other markets, we question whether patent pooling would offer the optimal balance of openness and incentive for CRISPR therapeutics.

Keywords: crispr, licensing, biotechnology, intellectual property, patents, pools, mpegla, genetics

JEL Classification: K00, K23, K41, O3, O34, D23, K11

Suggested Citation

Contreras, Jorge L. and Sherkow, Jacob S., Patent Pools for CRISPR Technology — Response (March 24, 2017). Science, Vol. 355(6331), pp. 1274-1275 (2017), Available at SSRN: https://ssrn.com/abstract=2993176

Jorge L. Contreras

University of Utah - S.J. Quinney College of Law ( email )

383 S. University Street
Salt Lake City, UT 84112-0730
United States

Jacob S. Sherkow (Contact Author)

University of Illinois College of Law ( email )

504 E. Pennsylvania Avenue
Champaign, IL 61820
United States

Carle Illinois College of Medicine ( email )

506 S Mathews Ave
Urbana, IL 61801
United States

University of Illinois at Urbana-Champaign - European Union Center ( email )

Coble Hall
801 S Wright St
Champaign, IL 61820

University of Illinois at Urbana-Champaign - Carl R. Woese Institute for Genomic Biology ( email )

Urbana, IL
United States

Do you have negative results from your research you’d like to share?

Paper statistics

Abstract Views
743
PlumX Metrics